Loading startup

DealFlow OS
Market indexPublic companiesMorning briefingTerminal
Request accessSign in

DealFlow

Terminal access

IndexTop moversSignals

Public markets

Public companiesMorning briefing
Browse index
C

CellType

SeedFunding signal
www.celltype.comHealthcareUnknown
Market index

Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.

Investor read

Evidence-bound summary — expand sections for movement, risks, and signals.

Memo snapshot · May 20, 2026, 6:29 PM

Worth a meetingEvidence-bound analyst verdict
  • •Funding: Raised $500K across 1 funding round. Latest: $500K Seed (Jan 2026). Investors: Y Combinator, Pioneer Fund.
  • •Named backers in indexed sources: Y Combinator, Pioneer Fund.
  • •Hiring: 3 hiring‑related row(s); role‑spam risk if mostly generic boards
  • •Product/news: 7 product/news‑styled row(s); headline risk without filings

DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.

TL;DR

Seed (YC)

CellType | The Biological World Model Agentic drug discovery using biological foundation models.

Funding

Raised $500K across 1 funding round. Latest: $500K Seed (Jan 2026). Investors: Y Combinator, Pioneer Fund. (High).

Quick read

  • •CellType | The Biological World Model Agentic drug discovery using biological foundation models.
  • •Reported angle: Launch YC: CellType: The Agentic Drug Company

Key signals

Funding

Raised $500K across 1 funding round. Latest: $500K Seed (Jan 2026). Investors: Y Combinator, Pioneer Fund. (High).

Hiring

3 hiring‑related row(s); role‑spam risk if mostly generic boards (High).

Product / news

7 product/news‑styled row(s); headline risk without filings (High).

Evidence summary

Verified facts

  • •CellType | The Biological World Model Agentic drug discovery using biological foundation models.
  • •Reported angle: Launch YC: CellType: The Agentic Drug Company

Recent movers

  • •May 20, 2026 · ycombinator.com — Launch YC: CellType: The Agentic Drug Company
  • •May 20, 2026 · ycombinator.com — CellType | Y Combinator
  • •May 11, 2026 · Blog / news — CellType | The Biological World Model

+5 more in Recent movement below

  • •May 20, 2026 · ycombinator.com — Launch YC: CellType: The Agentic Drug Company
  • •May 20, 2026 · ycombinator.com — CellType | Y Combinator
  • •May 11, 2026 · Blog / news — CellType | The Biological World Model
  • •May 11, 2026 · Careers — CellType | The Biological World Model
  • •May 10, 2026 · Press — CellType | The Biological World Model
  • •May 10, 2026 · News — CellType | The Biological World Model
  • •May 10, 2026 · Jobs page — CellType | The Biological World Model
  • •May 20, 2026 · biopharmatrend.com — Y Combinator Backs Yale Spinout CellType
  • •Y Combinator
  • •Pioneer Fund

Suggested next steps

  • ▸Open a founder conversation this month; validate traction claims against the indexed evidence.
  • ▸Add to the active watchlist so new signals trigger alerts.

Funding & hiring signals

funding_articleConfidence: low

Launch YC: CellType: The Agentic Drug Company

YC W26 Yale spinout building biological foundation models and agentic drug discovery.

Affected score: noObserved: May 20, 2026

Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.

funding_articleMay 20, 2026Confidence: high

CellType | Y Combinator

YC W26 agentic drug company profile.

Affected score: yesObserved: May 20, 2026
fundingraised

Open roles (indexed)

No open roles indexed yet.

Public index
97Activity 96/100Strong public activity signal
7D—
30D+26 (+36.6%)
High Confidence

The index price and activity score are algorithmic estimates based on observed public company-level signals. They may be incomplete, stale, or inaccurate and are not investment, legal, tax, or business advice.

Source health

  • public_market_enrichmentok
    Last checked Sun, Jun 28, 07:11 PM
  • public_page:_pressok
    Last checked Sun, Jun 28, 07:11 PM
  • public_page:_newsok
    Last checked Sun, Jun 28, 07:11 PM
  • public_page:_jobsok
    Last checked Sun, Jun 28, 07:11 PM
  • public_page:_companyok
    Last checked Sun, Jun 28, 07:11 PM
  • public_page:_careersok
    Last checked Sun, Jun 28, 07:11 PM
  • public_page:_blogok
    Last checked Sun, Jun 28, 07:11 PM
  • public_page:_aboutok
    Last checked Sun, Jun 28, 07:11 PM
  • public_page:_ok
    Last checked Sun, Jun 28, 07:11 PM
  • public_page:homeok
    Last checked Sun, Jun 28, 07:11 PM
  • public_page:customersok
    Last checked Sun, May 10, 10:50 PM
  • public_page:pricingok
    Last checked Sun, May 10, 10:50 PM
  • public_page:pressok
    Last checked Sun, May 10, 10:50 PM
  • public_page:newsok
    Last checked Sun, May 10, 10:50 PM
  • public_page:blogok
    Last checked Sun, May 10, 10:50 PM
  • public_page:jobsok
    Last checked Sun, May 10, 10:50 PM
  • public_page:careersok
    Last checked Sun, May 10, 10:50 PM
  • public_page:teamok
    Last checked Sun, May 10, 10:50 PM
  • public_page:aboutok
    Last checked Sun, May 10, 10:50 PM

Signal timeline

17 dated public signals · newest on the right

Funding
Hiring
Product
Press
Company
Other
Dec 25, 2025Apr 2, 2026Jul 9, 2026
Funding (2)Hiring (3)Product (2)Press (6)Company (3)Other (1)

Signal breakdown

Latest momentum signal per category. Expand a card to inspect raw payloads.

Public source summary

Total evidence rows
17
Latest evidence
Thu, Jul 2, 03:07 PM

Source types found

about_pageblogcareers_pagefounderfunding_articlehiringnewsofficial_sitepressproduct

Strongest / recent news-style rows

  • CellType | The Biological World Model

    Customers · Thu, Jul 2, 03:07 PM · confidence 45%high quality

  • CellType | The Biological World Model

    Pricing · Thu, Jul 2, 03:07 PM · confidence 45%high quality

  • CellType | The Biological World Model

    About page · Thu, Jul 2, 03:06 PM · confidence 45%high quality

Public signal timeline

Newest first · 17 event(s)

1
Thu, Jul 2, 03:07 PM · product · 45% · publichigh qualityCellType | The Biological World Model

Source: Customers

CellType | The Biological World Model

Source ↗
2
Thu, Jul 2, 03:07 PM · product · 45% · publichigh qualityCellType | The Biological World Model

Source: Pricing

CellType | The Biological World Model

Source ↗
3
Thu, Jul 2, 03:07 PM · blog · 45% · publichigh qualityCellType | The Biological World Model

Source: Blog

CellType | The Biological World Model

Source ↗
4
Thu, Jul 2, 03:06 PM · careers_page · 45% · publichigh qualityCellType | The Biological World Model

Source: Careers page

CellType | The Biological World Model

Source ↗
5
Thu, Jul 2, 03:06 PM · about_page · 45% · publichigh qualityCellType | The Biological World Model

Source: About page

CellType | The Biological World Model

Source ↗
6
Thu, Jul 2, 03:06 PM · official_site · 45% · publichigh qualityCellType | The Biological World Model

Source: Homepage

CellType | The Biological World Model

Source ↗
7
Sun, Jun 28, 07:11 PM · blog · 45% · publichigh qualityCellType | The Biological World Model

Source: Blog / news

CellType | The Biological World Model

Source ↗
8
Sun, Jun 28, 07:11 PM · blog · 45% · publichigh qualityCellType | The Biological World Model

Source: Blog / news

CellType | The Biological World Model

Source ↗
9
Sun, Jun 28, 07:11 PM · careers_page · 45% · publichigh qualityCellType | The Biological World Model

Source: Careers

CellType | The Biological World Model

Source ↗
10
Sun, Jun 28, 07:11 PM · about_page · 45% · publichigh qualityCellType | The Biological World Model

Source: About / company

CellType | The Biological World Model

Source ↗
11
Wed, May 20, 06:29 PM · funding_article · 88% · verified_publichigh qualityLaunch YC: CellType: The Agentic Drug Company

YC W26 Yale spinout building biological foundation models and agentic drug discovery.

Source ↗
12
Wed, May 20, 06:29 PM · funding_article · 85% · verified_publichigh qualityCellType | Y Combinator

YC W26 agentic drug company profile.

Source ↗
13
Sun, May 10, 10:50 PM · news · 45% · publichigh qualityCellType | The Biological World Model

Source: Press

CellType | The Biological World Model

Source ↗
14
Sun, May 10, 10:50 PM · news · 45% · publichigh qualityCellType | The Biological World Model

Source: News

CellType | The Biological World Model

Source ↗
15
Sun, May 10, 10:50 PM · hiring · 45% · publichigh qualityCellType | The Biological World Model

Source: Jobs page

CellType | The Biological World Model

Source ↗
16
Sun, May 10, 10:50 PM · founder · 45% · publichigh qualityCellType | The Biological World Model

Source: Team page

CellType | The Biological World Model

Source ↗
17
Wed, May 20, 06:29 PM · press · 85% · verified_publicmedium qualityY Combinator Backs Yale Spinout CellType

Press coverage of Yale spinout and preclinical failure reduction mission.

Source ↗

Official / company site

1 row(s)

The company's own site — the authoritative description of what they sell and to whom. Marketing-controlled, so treat claims as positioning rather than verified traction.

official_site·Thu, Jul 2, 03:06 PM·Confidence 45%high qualitypublic
CellType | The Biological World Model

CellType | The Biological World Model

Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.

Open source ↗

News

8 row(s)

Third-party press coverage. Independent reporting corroborates company claims; repeated coverage across outlets is a momentum signal.

product·Thu, Jul 2, 03:07 PM·Confidence 45%high qualitypublic
CellType | The Biological World Model

CellType | The Biological World Model

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
product·Thu, Jul 2, 03:07 PM·Confidence 45%high qualitypublic
CellType | The Biological World Model

CellType | The Biological World Model

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
about_page·Thu, Jul 2, 03:06 PM·Confidence 45%high qualitypublic
CellType | The Biological World Model

CellType | The Biological World Model

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
about_page·Sun, Jun 28, 07:11 PM·Confidence 45%high qualitypublic
CellType | The Biological World Model

CellType | The Biological World Model

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
news·Sun, May 10, 10:50 PM·Confidence 45%high qualitypublic
CellType | The Biological World Model

CellType | The Biological World Model

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
news·Sun, May 10, 10:50 PM·Confidence 45%high qualitypublic
CellType | The Biological World Model

CellType | The Biological World Model

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
founder·Sun, May 10, 10:50 PM·Confidence 45%high qualitypublic
CellType | The Biological World Model

CellType | The Biological World Model

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
press·Wed, May 20, 06:29 PM·Confidence 85%medium qualityverified_public
Y Combinator Backs Yale Spinout CellType

Press coverage of Yale spinout and preclinical failure reduction mission.

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗

Funding / news

2 row(s)

Funding announcements and investor-database records. The strongest public signal of capitalization: round, amount, and syndicate quality when disclosed.

funding_article·Wed, May 20, 06:29 PM·Confidence 88%high qualityverified_public
Launch YC: CellType: The Agentic Drug Company

YC W26 Yale spinout building biological foundation models and agentic drug discovery.

Why it matters: Funding signal — Seed per this source; verify against the linked original before relying on it.

Open source ↗
funding_article·Wed, May 20, 06:29 PM·Confidence 85%high qualityverified_public
CellType | Y Combinator

YC W26 agentic drug company profile.

Why it matters: Funding signal — capitalization evidence; check the linked source for round, amount, and investors.

Open source ↗

Hiring

3 row(s)

Open roles and careers pages. Active hiring implies runway to spend and shows where the company is investing (engineering vs GTM vs ops).

careers_page·Thu, Jul 2, 03:06 PM·Confidence 45%high qualitypublic
CellType | The Biological World Model

CellType | The Biological World Model

Why it matters: Hiring signal — open roles imply runway to spend and show where the company is investing.

Open source ↗
careers_page·Sun, Jun 28, 07:11 PM·Confidence 45%high qualitypublic
CellType | The Biological World Model

CellType | The Biological World Model

Why it matters: Hiring signal — open roles imply runway to spend and show where the company is investing.

Open source ↗
hiring·Sun, May 10, 10:50 PM·Confidence 45%high qualitypublic
CellType | The Biological World Model

CellType | The Biological World Model

Why it matters: Hiring signal — open roles imply runway to spend and show where the company is investing.

Open source ↗

Blog

3 row(s)

Company blog and newsletters. Shipping cadence and technical depth of posts hint at product velocity and team quality.

blog·Thu, Jul 2, 03:07 PM·Confidence 45%high qualitypublic
CellType | The Biological World Model

CellType | The Biological World Model

Why it matters: Company publishing — post cadence and depth hint at product velocity.

Open source ↗
blog·Sun, Jun 28, 07:11 PM·Confidence 45%high qualitypublic
CellType | The Biological World Model

CellType | The Biological World Model

Why it matters: Company publishing — post cadence and depth hint at product velocity.

Open source ↗
blog·Sun, Jun 28, 07:11 PM·Confidence 45%high qualitypublic
CellType | The Biological World Model

CellType | The Biological World Model

Why it matters: Company publishing — post cadence and depth hint at product velocity.

Open source ↗

Private workspace

Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.

Sign in
DealFlow OS · Public market terminal
Privacy PolicyTerms & Conditions